Commentary on Konstenius et al. (2014): on medication development for stimulant addiction

Affiliations

Comment

Steve Shoptaw. Addiction. 2014 Mar.

. 2014 Mar;109(3):450-1.

doi: 10.1111/add.12480.

¹ Department of Family Medicine, Center on Behavioral and Addiction Medicine, UCLA, Los Angeles, CA, 90095, USA. sshoptaw@mednet.ucla.edu.

No abstract available

Keywords: ADHD; amphetamine; criminal justice; medication development; methylphenidate; pharmacotherapy; stimulant dependence.

Comment on

Methylphenidate for attention deficit hyperactivity disorder and drug relapse in criminal offenders with substance dependence: a 24-week randomized placebo-controlled trial.
Konstenius M, Jayaram-Lindström N, Guterstam J, Beck O, Philips B, Franck J. Konstenius M, et al. Addiction. 2014 Mar;109(3):440-9. doi: 10.1111/add.12369. Epub 2013 Dec 1. Addiction. 2014. PMID: 24118269 Free PMC article. Clinical Trial.